Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition

This publication has 46 references indexed in Scilit:

• Phase I Study of Navitoclax (ABT-263), a Novel Bcl-2 Family Inhibitor, in Patients With Small-Cell Lung Cancer and Other Solid Tumors
  Journal of Clinical Oncology, 2011
• Methadone induces necrotic-like cell death in SH-SY5Y cells by an impairment of mitochondrial ATP synthesis
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
• Inhibition of Bcl-2 and Bcl-X enhances chemotherapy sensitivity in hepatoblastoma cells
  Pediatric Blood & Cancer, 2010
• Methadone, Commonly Used as Maintenance Medication for Outpatient Treatment of Opioid Dependence, Kills Leukemia Cells and Overcomes Chemoresistance
  Cancer Research, 2008
• Biology and Treatment of Acute Lymphoblastic Leukemia
  Pediatric Clinics of North America, 2008
• Initial testing (stage 1) of the BH3 mimetic ABT‐263 by the pediatric preclinical testing program
  Pediatric Blood & Cancer, 2007
• Killing cancer cells by flipping the Bcl-2/Bax switch
  Cancer Cell, 2005
• BCL-2 Expression in Childhood Leukemia Versus Spontaneous Apoptosis, Drug Induced Apoptosis, and in vitro Drug Resistance
  1999
• Nonconventional opioid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells.
  Proceedings of the National Academy of Sciences, 1992
• Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines.
  Proceedings of the National Academy of Sciences, 1990